United States Polymerase Chain Reaction (PCR) Market 2033 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The global polymerase chain reaction market size reached US$ 11.58 Billion in 2023 with a rise of US$ 12.33 Billion in 2024 and is expected to reach US$ 22.66 Billion by 2033, growing at a CAGR of 7.0% during the forecast period 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/polymerase-chain-reaction-market?sb

Key Development:

United States: Recent PCR Industry Developments

✅ In January 2026, PCR Biosystems launched its new Lyo‐Ready Inhibitor‐Tolerant reagents, bringing highly stable, ambient‐temperature qPCR and RT‐qPCR reagent chemistry into workflows that improve performance in inhibitor‐rich samples such as blood and saliva for molecular diagnostics.

✅ In November 2025, Co‐Dx began clinical performance testing for its Co‐Dx PCR Flu A/B, COVID‐19 and RSV multiplex test ahead of an intended U.S. FDA submission, marking progress toward next‐generation multiplex PCR testing platforms in respiratory diagnostics.

✅ In October 2025, PCR Biosystems expanded its reagent portfolio with enhanced lyophilisation‐ready chemistries, enabling assay developers to build more robust qPCR workflows that tolerate inhibitors and support decentralized testing environments.

✅ In October 2025, Co‐Dx's proprietary PCR platform (including the Co‐Dx PCR Pro instrument and test cups) continued under U.S. FDA regulatory review with ongoing development toward point‐of‐care and at‐home PCR diagnostics, reflecting investment in accessible PCR technologies.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=polymerase-chain-reaction-market

Japan: Recent PCR Industry Developments

✅ In January 2026, the National Agriculture and Food Research Organization (NARO) scheduled delivery of a Digital PCR System set under a government procurement notice, facilitating upgraded molecular analysis capacity for national research facilities.

✅ In December 2025, Japan's in‐vitro diagnostics market highlighted advancements in real‐time and PCR testing adoption, with clinical labs increasingly integrating PCR‐based molecular diagnostics into routine workflows to enhance diagnostic accuracy and turnaround times.

✅ In late 2025, microfluidic and multiplex PCR diagnostic panels capable of high‐throughput detection of respiratory and gastrointestinal pathogens gained traction in Japan's point‐of‐care segment, driven by innovation in cartridge‐based molecular tests that shrink thermal‐cycling volumes for faster results.

✅ In November-December 2025, Japanese research and diagnostics stakeholders continued to prioritize PCR diagnostics within broader molecular testing strategies, reflecting strong clinical demand for precision molecular tools across healthcare and hospital laboratory settings.

Key Players:

=> Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Abbott, QIAGEN, Bio-Rad Laboratories, Inc., Cepheid, Illumina, Inc., Takara Bio Inc., Standard BioTools, BD, and others.

Thermo Fisher Scientific Inc.: Thermo Fisher Scientific Inc. is a global leader in the PCR market, offering thermal cyclers, reagents, and consumables under brands like Applied Biosystems and Invitrogen. The company drives innovation in gene expression, genotyping, and diagnostics, supported by strategic investments and acquisitions, expanding its capabilities in molecular biology and clinical testing worldwide.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/polymerase-chain-reaction-market?sb

Key Segments:

By Product

Instruments - ~50% share

Core revenue driver, includes real-time, standard, and digital PCR machines used in diagnostics, research, and pharmaceutical applications.

Reagents and Consumables - ~35% share

Recurring revenue source, including PCR kits, primers, probes, and related consumables for laboratory operations.

Software - ~15% share

Analytical and data management software supporting PCR operations, increasingly important for high-throughput and automated workflows.

By Type

Real-time PCR Systems - ~45% share

Widely adopted for clinical diagnostics, pathogen detection, and quantitative gene expression analysis.

Standard PCR Systems - ~30% share

Used extensively in academic research, basic laboratory testing, and non-quantitative applications.

Digital PCR Systems - ~25% share

Growing segment due to high precision, low-volume detection, and emerging applications in oncology and rare mutation detection.

By Application

Medical Applications - ~55% share

Includes infectious disease diagnostics, oncology research, genetic disorder analysis, and COVID-19 testing.

Non-Medical Applications - ~30% share

Environmental testing, food safety, agricultural genomics, and industrial biotechnology.

Others - ~15% share

Research-grade or specialty applications not categorized under conventional medical or non-medical uses.

By End User

Hospitals and Clinics - ~40% share

Primary adopters for clinical diagnostics and patient care applications.

Diagnostic Centers - ~25% share

Specialized laboratories providing outsourced testing services for healthcare providers.

Pharmaceutical and Biotechnology Industries - ~20% share

Utilized in R&D, quality control, and drug development pipelines.

Academic and Research Organizations - ~10% share

Universities, research institutes, and labs conducting genomics, transcriptomics, and other molecular biology studies.

Others - ~5% share

Includes government labs, forensic institutions, and emerging application sectors.

FAQ

What is the current size of the Polymerase chain reaction Market?

A: In 2024, the Polymerase chain reaction Market was valued at US$ 12.33 Billion, reflecting its strong industry presence.

Q2: How large is the Polymerase chain reaction Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Polymerase chain reaction Market will grow to around US$ 22.66 Billion , demonstrating significant expansion.

Q3: What is the growth rate of the Polymerase chain reaction Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 7.0% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.